Regeneron Pharmaceuticals REGN

F. Ryan Arthur (Director) plans to sell 300 REGN shares, about $266,718

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: May 1, 2024
  2. Broker: J.P. Morgan Securities LLC
  3. Shares acquired by: Compensation
  4. 10b5-1 plan adopted: Aug 7, 2023

All of F. Ryan Arthur's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 7 shares at $891.52 on May 1, 2024 · Form 4
  • Sold 9 shares at $892.5 on May 1, 2024 · Form 4
  • Sold 5 shares at $893.16 on May 1, 2024 · Form 4
  • Sold 2 shares at $895.38 on May 1, 2024 · Form 4
  • Sold 3 shares at $896.59 on May 1, 2024 · Form 4
  • Sold 9 shares at $897.68 on May 1, 2024 · Form 4
  • Sold 17 shares at $898.51 on May 1, 2024 · Form 4
  • Sold 7 shares at $899.37 on May 1, 2024 · Form 4
  • Sold 5 shares at $900.45 on May 1, 2024 · Form 4
  • Sold 4 shares at $901.41 on May 1, 2024 · Form 4
  • Sold 1 shares at $903.35 on May 1, 2024 · Form 4
  • Sold 1 shares at $904.8 on May 1, 2024 · Form 4
  • Sold 2 shares at $905.5 on May 1, 2024 · Form 4
  • Sold 4 shares at $906.26 on May 1, 2024 · Form 4
  • Sold 2 shares at $907.54 on May 1, 2024 · Form 4
  • Sold 4 shares at $909.49 on May 1, 2024 · Form 4
  • Sold 6 shares at $910.47 on May 1, 2024 · Form 4
  • Sold 4 shares at $911.39 on May 1, 2024 · Form 4
  • Sold 1 shares at $912.29 on May 1, 2024 · Form 4
  • Sold 1 shares at $913.21 on May 1, 2024 · Form 4
  • Sold 2 shares at $979.4 on Jun 3, 2024 · Form 4
  • Sold 3 shares at $980.16 on Jun 3, 2024 · Form 4
  • Sold 3 shares at $981.95 on Jun 3, 2024 · Form 4
  • Sold 1 shares at $982.99 on Jun 3, 2024 · Form 4
  • Sold 2 shares at $984.52 on Jun 3, 2024 · Form 4
  • Sold 2 shares at $988.66 on Jun 3, 2024 · Form 4
  • Sold 4 shares at $990.74 on Jun 3, 2024 · Form 4
  • Sold 7 shares at $992.19 on Jun 3, 2024 · Form 4
  • Sold 12 shares at $993.2 on Jun 3, 2024 · Form 4
  • Sold 5 shares at $994.25 on Jun 3, 2024 · Form 4
  • Sold 6 shares at $995.76 on Jun 3, 2024 · Form 4
  • Sold 12 shares at $996.83 on Jun 3, 2024 · Form 4
  • Sold 15 shares at $997.76 on Jun 3, 2024 · Form 4
  • Sold 14 shares at $998.44 on Jun 3, 2024 · Form 4
  • Sold 7 shares at $999.43 on Jun 3, 2024 · Form 4
  • Sold 5 shares at $1,000.04 on Jun 3, 2024 · Form 4
  • Sold 3 shares at $1,047.11 on Jul 1, 2024 · Form 4
  • Sold 2 shares at $1,050.87 on Jul 1, 2024 · Form 4
  • Sold 7 shares at $1,051.58 on Jul 1, 2024 · Form 4
  • Sold 6 shares at $1,052.19 on Jul 1, 2024 · Form 4
  • Sold 8 shares at $1,053.6 on Jul 1, 2024 · Form 4
  • Sold 1 shares at $1,054.25 on Jul 1, 2024 · Form 4
  • Sold 2 shares at $1,056.81 on Jul 1, 2024 · Form 4
  • Sold 2 shares at $1,057.64 on Jul 1, 2024 · Form 4
  • Sold 17 shares at $1,058.49 on Jul 1, 2024 · Form 4
  • Sold 3 shares at $1,059.36 on Jul 1, 2024 · Form 4
  • Sold 3 shares at $1,060.14 on Jul 1, 2024 · Form 4
  • Sold 3 shares at $1,061.73 on Jul 1, 2024 · Form 4
  • Sold 19 shares at $1,062.31 on Jul 1, 2024 · Form 4
  • Sold 5 shares at $1,063.87 on Jul 1, 2024 · Form 4
  • Sold 7 shares at $1,064.55 on Jul 1, 2024 · Form 4
  • Sold 3 shares at $1,065.52 on Jul 1, 2024 · Form 4
  • Sold 4 shares at $1,066.59 on Jul 1, 2024 · Form 4
  • Sold 3 shares at $1,067.51 on Jul 1, 2024 · Form 4
  • Sold 2 shares at $1,068.09 on Jul 1, 2024 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Get an email when Regeneron Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

Data on this page was fetched . The filing on SEC.gov is the record.